A 1.1 Million Base Pair X-Chromosomal Deletion Covering the PDHA1 and CDKL5 Genes in a Female Patient with West Syndrome and Pyruvate Oxidation Deficiency

Abstract

Mutations in the X-linked E1α subunit of the pyruvate dehydrogenase complex (PHDC) are the most frequent causes of PDHC deficiency. The clinical picture is heterogeneous depending on residual enzyme activity and X-inactivation. We report on a girl who presented at an age of 3 weeks with muscular hypotonia, vomiting, hyperlactatemia, microcephaly, enlarged ventricles, partial agenesis of the corpus callosum, and seizures. PDHA1 sequencing was normal in DNA from blood. In muscle, normal PDHC activity was measured while substrate oxidation rates revealed moderately diminished pyruvate oxidation. Quantitative PCR analysis revealed hemizygosity of the whole PDHA1 gene. Homozygosity mapping and determination of the breakpoint showed a 1.1 million base pair deletion on the X-chromosome including the CDKL5 and PDHA1 genes. The difficulty in the diagnosis of PDHC deficiency is evident: (1) enzyme activity can be normal depending on the X-inactivation; (2) large deletions can be missed by routine genetic analysis; and (3) only quantification of the PDHA1 gene content revealed the mutation in our patient. We recommend to revisit patients who are clinically suspicious for a mitochondrial disorder especially for hidden PDHA1 mutations, such as large deletions.

Keywords

pyruvate dehydrogenase complex deficiency - mitochondrial disease - epilepsy - CDKL5 - X-inactivation

• References

• 1 Lissens W, De Meirleir L, Seneca S , et al. Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 2000; 15 (3) 209-219
• 2 Quintana E, Gort L, Busquets C , et al. Mutational study in the PDHA1 gene of 40 patients suspected of pyruvate dehydrogenase complex deficiency. Clin Genet 2010; 77 (5) 474-482
• 3 Strassburg HM, Koch J, Mayr J, Sperl W, Boltshauser E. Acute flaccid paralysis as initial symptom in 4 patients with novel E1alpha mutations of the pyruvate dehydrogenase complex. Neuropediatrics 2006; 37 (3) 137-141
• 4 Bahi-Buisson N, Nectoux J, Rosas-Vargas H , et al. Key clinical features to identify girls with CDKL5 mutations. Brain 2008; 131 (Pt 10) 2647-2661
• 5 Liang JS, Shimojima K, Takayama R , et al. CDKL5 alterations lead to early epileptic encephalopathy in both genders. Epilepsia 2011; 52 (10) 1835-1842
• 6 Weaving LS, Christodoulou J, Williamson SL , et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 2004; 75 (6) 1079-1093
• 7 Mayr JA, Bodamer O, Haack TB , et al. Heterozygous mutation in the X chromosomal NDUFA1 gene in a girl with complex I deficiency. Mol Genet Metab 2011; 103 (4) 358-361
• 8 Berger A, Mayr JA, Meierhofer D , et al. Severe depletion of mitochondrial DNA in spinal muscular atrophy. Acta Neuropathol 2003; 105 (3) 245-251
• 9 Mayr JA, Merkel O, Kohlwein SD , et al. Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation. Am J Hum Genet 2007; 80 (3) 478-484
• 10 Sperl W, Trijbels JM, Ruitenbeek W , et al. Measurement of totally activated pyruvate dehydrogenase complex activity in human muscle: evaluation of a useful assay. Enzyme Protein 1993; 47 (1) 37-46
• 11 Brown RM, Brown GK. X chromosome inactivation and the diagnosis of X linked disease in females. J Med Genet 1993; 30 (3) 177-184
• 12 Okajima K, Warman ML, Byrne LC, Kerr DS. Somatic mosaicism in a male with an exon skipping mutation in PDHA1 of the pyruvate dehydrogenase complex results in a milder phenotype. Mol Genet Metab 2006; 87 (2) 162-168
• 13 Ridout CK, Brown RM, Walter JH, Brown GK. Somatic mosaicism for a PDHA1 mutation in a female with pyruvate dehydrogenase deficiency. Hum Genet 2008; 124 (2) 187-193
• 14 Brivet M, Moutard ML, Zater M , et al. First characterization of a large deletion of the PDHA 1 gene. Mol Genet Metab 2005; 86 (4) 456-461
• 15 Singer BH, Iyer RK, Kerr DS, Ahmad A. Deletion at chromosomal band Xp22.12-Xp22.13 involving PDHA1 in a patient with congenital lactic acidosis. Mol Genet Metab 2010; 101 (1) 87-89
• 16 Mei D, Marini C, Novara F , et al. Xp22.3 Genomic deletions involving the CDKL5 gene in girls with early onset epileptic encephalopathy. Epilepsia 2009; 51 (7) 647-654
• 17 Hendrickx J, Lee P, Keating JP , et al. Complete genomic structure and mutational spectrum of PHKA2 in patients with x-linked liver glycogenosis type I and II. Am J Hum Genet 1999; 64 (6) 1541-1549
• 18 Consortium TR ; The Retinoschisis Consortium. Functional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis. Hum Mol Genet 1998; 7 (7) 1185-1192